Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation [Phase 3]
Phase 3 clinical trial evaluating PSMA-PET and multiparametric MRI in high-risk prostate cancer with histopathologic validation; currently r…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months. [Phase 3]
A Phase 3 clinical trial is evaluating 6 versus 12 months of hormonal therapy for unfavorable intermediate-risk prostate cancer, and the stu…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer
A clinical trial is recruiting to compare triple therapy versus double therapy for patients with high-volume metastatic hormone-sensitive pr…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer [Phase 1]
The Phase 1 trial of oral EPI-7386 in patients with castration-resistant prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Effectiveness of Localized Prostate Cancer Treatments
Clinical trial update assessing the effectiveness of localized treatments for prostate cancer (NCT01492751). The study is currently not recr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC [Phase 1, Phase 2]
A Phase 1/2 trial evaluating EPI-7386 in combination with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study [Phase 2]
The Phase 2 PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study for prostate cancer was terminated, and results were posted on 2025-02-2…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: A Study of SHR-4394 Injection in Subjects With Prostate Cancer [Phase 1]
Phase 1 trial update for SHR-4394 injection in prostate cancer subjects. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer
This clinical trial update shows Kuopio University Hospital is recruiting for a Lutetium-177-PSMA study in PSMA PET-positive metastatic pros…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence [Phase 3]
Phase 3 imaging trial evaluating the safety and diagnostic performance of the 18F rhPSMA-7.3 PET ligand in suspected prostate cancer recurre…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer. [Phase 3]
Phase 3 imaging trial evaluating rhPSMA 7.3 (18F) for safety and diagnostic performance in newly diagnosed prostate cancer has completed and…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Weight Management Aimed to Reduce Risk and Improve Outcomes From Radical Prostatectomy [NA]
This clinical trial evaluated a weight management intervention aimed at reducing risk and improving outcomes after radical prostatectomy in …
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer [Phase 1]
Phase 1 trial completed evaluating uptake of the radiotracer [68Ga]P16-093 in metastatic prostate cancer and metastatic renal cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors [NA]
Completed update for the BurnAlong Pilot Study evaluating a program for adolescent and young adult cancer survivors. The study spans multipl…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer [NA]
This update reports that a clinical trial evaluating a rectal spacer hydrogel to reduce radiation exposure to the rectum during prostate can…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: IIT2020-20-SHIRAZIP-WALK: Nature Walks [NA]
The IIT2020-20-SHIRAZIP-WALK trial sponsored by Cedars-Sinai Medical Center has completed, studying breast cancer and several hematologic ma…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Pilot Study of (MR) Imaging with Pyruvate (13C) to Detect High Grade Prostate Cancer [EARLY_Phase 1]
This is an early-phase 1 pilot trial investigating magnetic resonance imaging using carbon-13 pyruvate to detect high-grade prostate cancer …
-
CLINICAL_TRIALS withdrawal · 2025-02-25Clinical Trial Update: Study of rSIFN-co for Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of rSIFN-co for advanced solid tumors has been terminated, involving malignancies including melanoma, kidney cancer…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform [NA]
A clinical trial comparing the HUGO RAS robotic platform with the Da Vinci robotic platform in patients with prostate cancer and renal cell …
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Optimizing Prostate Biopsy Schemes in Men With Multiple mpMRI Visible Lesions [NA]
A clinical trial being conducted at Peking University First Hospital aims to optimize biopsy schemes for men with multiple mpMRI-visible les…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: The Efficacy of Mapping for Cognitive Prostate Biopsy [NA]
A Marmara University-sponsored clinical trial evaluating the efficacy of mapping for cognitive prostate biopsy in prostate cancer has comple…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Internet-based Support for Adjustment to Prostate Cancer [NA]
An internet-based support program to help patients adjust to prostate cancer is being studied in a clinical trial. The study targets outcome…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: CyberKnife Dose Escalation Prostate Cancer Trial [NA]
This document reports an ongoing CyberKnife dose-escalation trial for prostate cancer that is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients [NA]
A Netherlands-based clinical trial is evaluating whether PSMA-PET/CT can be used to triage pelvic lymph node dissection in patients with pro…
-
CLINICAL_TRIALS other · 2025-02-21Clinical Trial Update: Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial [Phase 2]
RELAX is a Phase 2 randomized trial evaluating reduced length of androgen deprivation therapy and androgen receptor-targeted agent therapy w…